CBD, a three-letter word that has slowly been creeping into our visionary space. Yet, just like Bitcoin, it is an elusive money-making machine. To the converted, it is a miracle drug that fits a very tight space between a rock and a hard place. It is legal, accessible and most importantly, it works! It does not have any known long-term impact. The current market size of CBD is around $8 Billion dollars within the US alone. The gamut of customers ranges from patients of severe epilepsy disorder up to normal productive adults requiring a non-addictive safe supplement to deal with anxiety and stress. So, the real question is, how high can one’s investment go with CBD? Based on current predictions, very high.
What is CBD?
CBD, or fondly known as cannabidiol by chemical engineers, is a phytocannabinoid discovered in the 40s in the hemp plant. It gives its user a blissfully calm sensation without the long tentacles of addiction. CBD, until recently, has been negatively associated to drugs and drug-related crimes. An orally administered cannabidiol solution (brand name Epidiolex) was approved by the US Food and Drug Administration in June 2018 as a treatment for two rare forms of childhood epilepsy, Lennox-Gastaut syndrome and Dravet syndrome. This was the break-through that many investors were looking forward to. By having legal and legitimate use, CBD is now set to take on the mainstream world of pain management and lifestyle supplementary.
Myth-busting about CBD
Given the attraction of a plant-based relaxant, there’s been many myths around CBD. Here are some quick CBD myth-busting facts
- CBD hemp oils are NOT psychoactive, unlike cannabis. The THC content in CBD is low, making non-psychoactive.
- CBD is NOT sedating, it is actually alerting. CBD has been shown to counteract the sedative effects of THC, delay sleep time, and reduce THC-associated “hangover.”
- CBD is almost legal. According to the Controlled Substances Act, CBD is considered a member of the group of “tetrahydrocannabinols. It is authorized for investigation as a new drug for which substantial clinical investigations have been instituted and for which the existence of such investigations has been made public.
- CBD is not just for music celebrities and curious teenagers. As it’s been gaining popularity, CBD has been gaining endorsement from high-profile doctors such as Dr Sanjay Gupta, a famous neuro-surgeon and Emmy-award winning medical reporter.